Pathway analysis in HEK 293T cells overexpressing HIV-1 tat and nucleocapsid

Journal of Microbiology and Biotechnology

Volumn 19, Issue 10, 2009, Pages 1103-1108

  Lee, Min Joo ^a   Park, Jong Hoon ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

HIV; Microarray; Nucleocapsid; Pathway analysis; Tat

Indexed keywords

MESSENGER RNA; NUCLEOCAPSID PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL STRAIN HEK293; DNA MICROARRAY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VIRUS ENTRY; VIRUS NUCLEOCAPSID; VIRUS REPLICATION;

GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 70849127030     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.0903.03005     Document Type: Article

References (33)

1. Albini, A., R. Soldi, D. Giunciuglio, E. Giraudo, R. Benelli, L. Primo, et al. 1996. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat. Med. 2: 1371-1375.
2. Bacharach, E., J. Gonsky, K. Alin, M. Orlova, and S. P. Goff. 2000. The carboxy-terminal fragment of nucleolin interacts with the nucleocapsid domain of retroviral Gag proteins and inhibits virion assembly. J. Virol. 74: 11027-11039. (Pubitemid 32223968)
3. Belka, C., C. Gruber, V. Jendrossek, S. Wesselborg, and W. Budach. 2003. The tyrosine kinase Lck is involved in regulation of mitochondrial apoptosis pathways. Oncogene 22: 176-185. (Pubitemid 36174175)
4. Bettaccini, A. A., A. Baj, R. S. Accolla, F. Basolo, and A. Q. Toniolo. 2005. Proliferative activity of extracellular HIV-1 Tat protein in human epithelial cells: Expression profile of pathogenetically relevant genes. BMC Microbiol. 5: 20.
5. Biswas, D. K., T. R. Salas, F. Wang, C. M. Ahlers, B. J. Dezube, and A. B. Pardee. 1995. A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter. J. Virol. 69: 7437-7444.
6. Boshoff, C. and R. Weiss. 2002. AIDS-related malignancies. Nat. Rev. Cancer 2: 373-382.
7. Brigati, C., M. Giacca, D. M. Noonan, and A. Albini. 2003. HIV Tat, its TARgets and the control of viral gene expression. FEMS Microbiol. Lett. 220: 57-65.
8. Cakmak, A. and G. Ozsoyoglu. 2007. Mining biological networks for unknown pathways. Bioinformatics 23: 2775-2783.
9. Choi, J., R. M. Liu, R. K. Kundu, F. Sangiorgi, W. Wu, R. Maxson, and H. J. Forman. 2000. Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice. J. Biol. Chem. 275: 3693-3698.
10. Cohen, K. B. and L. Hunter. 2008. Getting started in text mining. PLoS Comput. Biol. 4: e20.
11. Dayton, A. I., J. G. Sodroski, C. A. Rosen, W. C. Goh, and W. A. Haseltine. 1986. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell 44: 941-947.
12. Deregibus, M. C., V. Cantaluppi, S. Doublier, M. F. Brizzi, I. Deambrosis, A. Albini, and G. Camussi. 2002. HIV-1-Tat protein activates phosphatidylinositol 3-kinase/AKT-dependent survival pathways in Kaposi's sarcoma cells. J. Biol. Chem. 277: 25195-25202.
13. Ensoli, B., L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R. A. Morgan, P. Wingfield, and R. C. Gallo. 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67: 277-287.
14. Fisher, A. G., M. B. Feinberg, S. F. Josephs, M. E. Harper, L. M. Marselle, G. Reyes, et al. 1986. The trans-activator gene of HTLV-III is essential for virus replication. Nature 320: 367-371. (Pubitemid 16077280)
15. Freed, E. O. 2001. HIV-1 replication. Somat. Cell Mol. Genet. 26: 13-33.
16. Freed, E. O. and M. A. Martin. 2007. HIVs and their replication. pp. 2107, In D. M. Knipe and P. M. Howley (eds.). Fields Virology. Lippincott Williams & Wilkins, Philadelphia.
17. Ganju, R. K., N. Munshi, B. C. Nair, Z. Y. Liu, P. Gill, and J. E. Groopman. 1998. Human immunodeficiency virus Tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells. J. Virol. 72: 6131-6137.
18. Gupta, S. and D. Mitra. 2007. Human immunodeficiency virus-1 Tat protein: Immunological facets of a transcriptional activator. Indian J. Biochem. Biophys. 44: 269-275.
19. Ideker, T. and R. Sharan. 2008. Protein networks in disease. Genome Res. 18: 644-652.
20. Menegon, A., C. Leoni, F. Benfenati, and F. Valtorta. 1997. Tat protein from HIV-1 activates MAP kinase in granular neurons and glial cells from rat cerebellum. Biochem. Biophys. Res. Commun. 238: 800-805.
21. Nisole, S., B. Krust, and A. G. Hovanessian. 2002. Anchorage of HIV on permissive cells leads to coaggregation of viral particles with surface nucleolin at membrane raft microdomains. Exp. Cell Res. 276: 155-173.
22. Opalenik, S. R., Q. Ding, S. R. Mallery, and J. A. Thompson. 1998. Glutathione depletion associated with the HIV-1 TAT protein mediates the extracellular appearance of acidic fibroblast growth factor. Arch. Biochem. Biophys. 351: 17-26.
23. Peruzzi, F. 2006. The multiple functions of HIV-1 Tat: Proliferation versus apoptosis. Front. Biosci. 11: 708-717.
24. Richard, M. J., P. Guiraud, C. Didier, M. Seve, S. C. Flores, and A. Favier. 2001. Human immunodeficiency virus type 1 Tat protein impairs selenoglutathione peroxidase expression and activity by a mechanism independent of cellular selenium uptake: Consequences on cellular resistance to UV-A radiation. Arch. Biochem. Biophys. 386: 213-220.
25. Rusnati, M. and M. Presta. 2002. HIV-1 Tat protein and endothelium: From protein/cell interaction to AIDS-associated pathologies. Angiogenesis 5: 141-151. (Pubitemid 36687517)
26. Simon, J. H., N. C. Gaddis, R. A. Fouchier, and M. H. Malim. 1998. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat. Med. 4: 1397-1400.
27. Stephensen, C. B., G. S. Marquis, S. D. Douglas, L. A. Kruzich, and C. M. Wilson. 2007. Glutathione, glutathione peroxidase, and selenium status in HIV-positive and HIV-negative adolescents and young adults. Am. J. Clin. Nutr. 85: 173-181.
28. Treitinger, A., C. Spada, J. C. Verdi, A. F. Miranda, O. V. Oliveira, M. V. Silveira, P. Moriel, and D. S. Abdalla. 2000. Decreased antioxidant defence in individuals infected by the human immunodeficiency virus. Eur. J. Clin. Invest. 30: 454-459.
29. Wain-Hobson, S., P. Sonigo, O. Danos, S. Cole, and M. Alizon. 1985. Nucleotide sequence of the AIDS virus, LAV. Cell 40: 9-17. (Pubitemid 15169301)
30. Webb, C., T. Lehman, K. McCord, P. Avery, and S. Dow. 2008. Oxidative stress during acute FIV infection in cats. Vet. Immunol. Immunopathol. 122: 16-24.
31. White, M. K., T. S. Gorrill, and K. Khalili. 2006. Reciprocal transactivation between HIV-1 and other human viruses. Virology 352: 1-13.
32. Yuryev, A., Z. Mulyukov, E. Kotelnikova, S. Maslov, S. Egorov, A. Nikitin, N. Daraselia, and I. Mazo. 2006. Automatic pathway building in biological association networks. BMC Bioinformatics 7: 171.
33. Zanetti, A., M. G. Lampugnani, G. Balconi, F. Breviario, M. Corada, L. Lanfrancone, and E. Dejana. 2002. Vascular endothelial growth factor induces SHC association with vascular endothelial cadherin: A potential feedback mechanism to control vascular endothelial growth factor receptor-2 signaling. Arterioscler. Thromb. Vasc. Biol. 22: 617-622.